FORT DETRICK, Md. – A process developed by the Medical Research and Development Command’s Medical Technology Transfer Office to help inventors ensure their biomedical technologies are ready for ...

AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning ...

The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...

Cibus, Inc. announced significant advancements in its gene editing technology, particularly the establishment of production standards for its proprietary RTDS gene editing system, which enables the ...

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...

The sudden emergence of ChatGPT in 2022 kicked off a race to create new products powered by generative artificial intelligence (AI). Now, companies in all industries are trying to build the ability to ...

One challenge for innovators at MSK and elsewhere is that technology development is costly and funding options are limited—especially once the potential for federal grant funding has been exhausted.

Aberdeen Proving Ground, MD -- Army leaders have long sought to simplify the process by which a good idea is transformed into innovative technology in the hands of warfighters. The steps in the ...

Nylon is one of the most widely used engineering thermoplastics due to its excellent mechanical properties, such as high ...

Isaac T. Kohlberg will step down from his role as Harvard’s chief technology development officer at the end of 2025, concluding a 20-year tenure during which he established and expanded the office ...